Kwmg LLC Trims Stock Holdings in Cardinal Health, Inc. $CAH

Key Points

• Kwmg LLC has reduced its stake in Cardinal Health, Inc. by 4.0%, owning 114,093 shares after selling 4,743 shares, with their holdings valued at approximately $19.17 million.
• Analysts have set new price targets for Cardinal Health, with Robert W. Baird raising it to $203.00 and Bank of America increasing it to $170.00, while the average target price currently stands at $165.93.
• Insider sales included CEO Jason M. Hollar selling 107,705 shares at an average price of $148.90, representing a 31.35% decrease in his position.

Kwmg LLC reduced its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 4.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 114,093 shares of the company's stock after selling 4,743 shares during the period. Cardinal Health makes up 1.8% of Kwmg LLC's portfolio, making the stock its 15th biggest position. Kwmg LLC's holdings in Cardinal Health were worth $19,168,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently modified their holdings of the company. Greykasell Wealth Strategies Inc. purchased a new stake in shares of Cardinal Health in the first quarter worth $26,000. Tompkins Financial Corp grew its stake in shares of Cardinal Health by 106.7% in the first quarter. Tompkins Financial Corp now owns 248 shares of the company's stock worth $34,000 after acquiring an additional 128 shares during the last quarter. GW&K Investment Management LLC grew its stake in shares of Cardinal Health by 113.4% in the first quarter. GW&K Investment Management LLC now owns 271 shares of the company's stock worth $37,000 after acquiring an additional 144 shares during the last quarter. NBC Securities Inc. purchased a new stake in shares of Cardinal Health in the first quarter worth $48,000. Finally, Zions Bancorporation National Association UT purchased a new stake in shares of Cardinal Health in the first quarter worth $52,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

CAH has been the topic of a number of recent research reports. Robert W. Baird increased their target price on Cardinal Health from $197.00 to $203.00 and gave the stock an "outperform" rating in a research note on Wednesday, August 13th. Argus set a $189.00 target price on Cardinal Health in a research note on Friday, August 22nd. Bank of America upped their price target on Cardinal Health from $165.00 to $170.00 and gave the company a "buy" rating in a report on Tuesday, June 10th. UBS Group reaffirmed a "buy" rating on shares of Cardinal Health in a report on Tuesday, August 12th. Finally, Wall Street Zen downgraded Cardinal Health from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 2nd. Eleven research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $165.93.

Insider Activity

In related news, insider Michelle D. Greene sold 13,500 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the sale, the insider owned 14,976 shares of the company's stock, valued at approximately $2,228,728.32. This trade represents a 47.41% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Jason M. Hollar sold 107,705 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.90, for a total value of $16,037,274.50. Following the sale, the chief executive officer directly owned 235,901 shares in the company, valued at $35,125,658.90. This trade represents a 31.35% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 271,676 shares of company stock worth $40,489,525. 0.12% of the stock is currently owned by corporate insiders.

Cardinal Health Stock Down 1.3%

CAH stock opened at $147.61 on Tuesday. Cardinal Health, Inc. has a twelve month low of $106.54 and a twelve month high of $168.44. The stock has a market cap of $35.07 billion, a P/E ratio of 22.89, a PEG ratio of 1.27 and a beta of 0.73. The business's 50-day moving average price is $152.78 and its 200-day moving average price is $148.84.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, beating analysts' consensus estimates of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The firm had revenue of $60.16 billion for the quarter, compared to analysts' expectations of $60.91 billion. During the same period in the previous year, the firm earned $1.84 EPS. The business's quarterly revenue was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, equities research analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be given a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date of this dividend is Wednesday, October 1st. Cardinal Health's payout ratio is presently 31.63%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.